Global Peptic Ulcer Drugs Market 2014-2018: Key Vendors are AstraZeneca, Eisai, Daewoong and Takeda - Beckley, Bluefield & Lewisburg News, Weather, Sports

Global Peptic Ulcer Drugs Market 2014-2018: Key Vendors are AstraZeneca, Eisai, Daewoong and Takeda

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, Ireland, August 29, 2014 /PRNewswire/ --

 

Research and Markets (http://www.researchandmarkets.com/research/jjj5vs/global_peptic) has announced the addition of the "Global Peptic Ulcer Drugs Market 2014-2018" report to their offering. 

A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer. 

The analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018.

This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.


Key Topics Covered: 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Product Profiles

05. Market Research Methodology

06. Introduction

07. Market Landscape

08. Pipeline Portfolio

09. Market Segmentation by Class of Drugs

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis


Companies Mentioned:

  • AstraZeneca plc
  • Eisai Co. Ltd.
  • Daewoong Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Eumedica
  • Ferring Pharmaceuticals
  • Horizon Pharma
  • Johnson and Johnson
  • Merck Sharp and Dohme
  • Otsuka Holdings
  • Pfizer
  • PharmaKing
  • Pozen
  • Rottapharm Madaus
  • Taiho Pharmaceutical
  • Zeria Pharmaceutical and Zuventus Healthcare


For more information visit http://www.researchandmarkets.com/research/jjj5vs/global_peptic


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


©2012 PR Newswire. All Rights Reserved.